We are pleased to welcome聽Dr. Stephan Blinder as the new BIC PET physicist on staff.聽
Stephan completed his PhD in Astrophysics (U de Bordeaux I, France) and later shifted his interest towards biomedical imaging research. He worked for 4 years with the MIRG group led by Dr. Anna Celler (U of British Columbia, Vancouver) on SPECT imaging, focusing on 3D and 4D image reconstruction techniques.聽
Category:
Published on: 6 Feb 2017
CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research
CQDM and Brain Canada are proud to announce the funding of two new multi-disciplinary and multi-institutional research projects under the second edition of their Focus on Brain strategic initiative. The partners will award a total of $3M to two research teams to develop cutting-edge tools, technologies and platforms designed to accelerate the discovery of new drugs for brain and nervous system disorders.
Category:
Published on: 2 Feb 2017
Project will enhance mental health access for multicultural communities
On Jan. 18, 2017, Bell Let鈥檚 Talk announced a donation of $250,000 to 平特五不中鈥檚 Montreal Neurological Institute and Hospital 鈥� known as The Neuro 鈥� to fund the development of online mental health resources focused on the needs of multicultural communities.
Published on: 18 Jan 2017
An all-star lineup of experts in the fields of sports and neurology will share a stage on Jan. 27 to discuss concussions, a serious injury that has only recently been getting the attention it deserves.
Category:
Published on: 11 Jan 2017
Have you ever met someone who just wasn鈥檛 into music? They may have a condition called specific musical anhedonia, which affects three-to-five per cent of the population.
Researchers at the University of Barcelona and the Montreal Neurological Institute and Hospital of 平特五不中 have discovered that people with this condition showed reduced functional connectivity between cortical regions responsible for processing sound and subcortical regions related to reward.
Category:
Published on: 4 Jan 2017
Drug shown to reduce new attacks/symptom progression in some patients
In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.
Category:
Published on: 22 Dec 2016
Truly happy to see聽Ted join聽our core staff as Manager, Data Resources. Ted聽has 12+ years experience as a programmer, database administrator and technology generalist in the industry and academia. He will assist in creating a strategy and enabling the tools for short- and long-term data management over all modalities used at our Centre, all in coordination with the developments of the MNI's open-science infrastructure.聽
Ted will draw from several years supporting open source, open data, and open science through policy and organizing.聽
Category:
Published on: 13 Dec 2016
Each December for over 60 years, the Reitman family has invited all members of The Neuro to a splendid luncheon that has become an enjoyable annual tradition. This gathering shows a wonderful holiday spirit of generosity and thankfulness.
Reitman family members, Joel (President of Jillcy Investments Ltd.), Jill and Dorothy were present for the 69th Reitman Holiday Luncheon on December 9th to greet staff and to help staff volunteers serve a tasty meal to some 1,200 members of The Neuro.
Category:
Published on: 9 Dec 2016
Study tracks patients to better understand effects and possible treatments
December 1 is World AIDS Day, a time to raise awareness about a disease that has afflicted 70 million people worldwide, 35 million of whom have died as a result.
Category:
Published on: 1 Dec 2016
Researchers have linked a debilitating neurological disease in children to mutations in a gene that regulates neuronal development through control of protein movement within neuronal cells.
Category:
Published on: 28 Nov 2016
Two researchers at the Montreal Neurological Institute and Hospital (MNI) of 平特五不中 have received funding to study a devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk.
Category:
Published on: 24 Nov 2016
MNI scientists will study stem cells, genetic mutations to develop new treatments
Researchers at the Montreal Neurological Institute of 平特五不中 who are playing key roles in uncovering the mechanisms underlying ALS will share in $3.9 million in research funding, part of $4.5 million announced on Nov. 23 by the ALS Society of Canada in partnership with Brain Canada.
Category:
Published on: 23 Nov 2016
When two people smell the same thing, they can have remarkably different reactions, depending on their cultural background. Researchers at the Neuro have found that even when two cultures share the same language and many traditions, their reactions to the same smells can be different.
Category:
Published on: 21 Nov 2016
#GivingTuesday is a global day of giving, created to counteract the consumerism-based Black Friday and Cyber Monday.
This year, The Neuro is celebrating #GivingTuesday by inviting the community to fund the Giving Tuesday Travel Award 鈥� which will allow a talented student or fellow to present their research at a national or international scientific meeting.
Category:
Published on: 8 Nov 2016
2016 Prix Wilder-Penfield recognizes monumental work in brain imaging and mapping
Dr. Alan Evans has become the latest researcher to receive the Province of Quebec鈥檚 most prestigious scientific award, the 2016 Prix Wilder-Penfield, named after The Neuro鈥檚 founder.聽
Category:
Published on: 5 Nov 2016
Pages
